Literature DB >> 16359285

Abnormal heart rate turbulence predicts the initiation of ventricular arrhythmias.

Atsushi Iwasa1, Michael Hwa, Alborz Hassankhani, Taylor Liu, Sanjiv M Narayan.   

Abstract

BACKGROUND: Abnormal heart rate turbulence (HRT) reflects autonomic derangements predicting all-cause mortality, yet has not been shown to predict ventricular arrhythmias in at-risk patients. We hypothesized that HRT at programmed ventricular stimulation (PVS) would predict arrhythmia initiation in patients with left ventricular dysfunction.
METHODS: We studied 27 patients with coronary disease, left ventricular ejection fraction (LVEF) 26.7 +/- 9.1%, and plasma B-type natriuretic peptide (BNP) 461 +/- 561 pg/mL. Prior to arrhythmia induction at PVS, we measured sinus cycles after spontaneous or paced premature ventricular contractions (PVCs) for turbulence onset (TO; % cycle length change following PVC) and slope (TS; greatest slope of return to baseline cycle). T-wave alternans (TWA) was also measured during atrial pacing.
RESULTS: At PVS, abnormal TO (> or =0%) predicted inducible ventricular tachycardia (VT; n = 10 patients; P < 0.05). TO was greater in inducible than in noninducible patients (2.3 +/- 3.1% vs -0.02 +/- 2.8%, P < 0.05) and correlated with LVEF (P < 0.05) but not with BNP. TS did not differ between groups. Conversely, ambulatory HRT differed significantly from HRT at PVS (TO -0.55 +/- 1.08% vs 0.85 +/- 3.02%, P < 0.05; TS 2.63 +/- 2.09 ms/RR vs 8.70 +/- 6.56 ms/RR, P < 0.01), and did not predict inducible VT but trended (P = 0.05) to predict sustained VT on 739 +/- 179 days follow-up. TWA predicted inducible (P < 0.05) and spontaneous (P = 0.0001) VT but did not co-migrate with HRT.
CONCLUSIONS: Abnormal HRT measured at PVS predicted the induction of sustained ventricular arrhythmias in patients with ischemic cardiomyopathy. However, HRT at PVS did not correlate with ambulatory HRT, nor with TWA, both of which predicted spontaneous ventricular arrhythmias. Thus, HRT may reflect the influence of autonomic milieu on arrhythmic susceptibility and is likely complementary to traditional arrhythmic indices.

Entities:  

Mesh:

Year:  2005        PMID: 16359285     DOI: 10.1111/j.1540-8159.2005.50186.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Influence of heavy cigarette smoking on heart rate variability and heart rate turbulence parameters.

Authors:  Goksel Cagirci; Serkan Cay; Ozlem Karakurt; Neslihan Eryasar; Veli Kaya; Aytun Canga; Asuman Bicer Yesilay; Harun Kilic; Serkan Topaloglu; Dursun Aras; Ahmet Duran Demir; Ramazan Akdemir
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

2.  Ventricular arrhythmias and changes in heart rate preceding ventricular tachycardia in patients with an implantable cardioverter defibrillator.

Authors:  Claudia Lerma; Niels Wessel; Alexander Schirdewan; Jürgen Kurths; Leon Glass
Journal:  Med Biol Eng Comput       Date:  2008-03-15       Impact factor: 2.602

3.  Robust detection of premature ventricular contractions using a wave-based Bayesian framework.

Authors:  Omid Sayadi; Mohammad B Shamsollahi; Gari D Clifford
Journal:  IEEE Trans Biomed Eng       Date:  2009-09-15       Impact factor: 4.538

Review 4.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

5.  Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway.

Authors:  Eva R Serber; Joseph L Fava; Lillian M Christon; Alfred E Buxton; Jeffrey J Goldberger; Michael R Gold; James R Rodrigue; Michael B Frisch
Journal:  Pacing Clin Electrophysiol       Date:  2016-02-24       Impact factor: 1.976

6.  Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis.

Authors:  Adam R Poliwczak; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Katarzyna Dworniak-Pryca
Journal:  Postepy Dermatol Alergol       Date:  2019-02-26       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.